Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 4, 2014, Pages 358-369

  Schober, Michelle E ^a   Requena, Daniela F ^b   Block, Benjamin ^b   Davis, Lizeth J ^b   Rodesch, Christopher ^b   Casper, T Charles ^a   Juul, Sandra E ^c   Kesner, Raymond P ^b   Lane, Robert H ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; controlled cortical impact; developmental; EPO; memory

Indexed keywords

ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN INJURIES; CASPASES; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; EXPLORATORY BEHAVIOR; HEMATOCRIT; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECOGNITION (PSYCHOLOGY); RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 84893917681     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.2922     Document Type: Article

References (76)

1. Langlois JA, Rutland-Brown W, and Thomas KE. (2005). The incidence of traumatic brain injury among children in the United States: Differences by race. J Head Trauma Rehabil 20:229-238
2. Langlois JA, Rutland-Brown W, and Wald MM. (2006). The epidemiology and impact of traumatic brain injury: A brief overview. J Head Trauma Rehabil 21:375-378
3. Yeates KO, Taylor HG, Wade SL, Drotar D, Stancin T, and Minich N. (2002). A prospective study of short- and long-term neuropsychological outcomes after traumatic brain injury in children. Neuropsychology 16:514-523
4. Yeates KO, Armstrong K, Janusz J, Taylor HG, Wade S, Stancin T, and Drotar D. (2005). Long-term attention problems in children with traumatic brain injury. J Am Acad Child Adolesc Psychiatry 44:574-584
5. Catroppa C, and Anderson V. (2007). Recovery in memory function, and its relationship to academic success, at 24 months following pediatric TBI. Child Neuropsychology 13:240-261
6. Anderson V, Godfrey C, Rosenfeld JV, and Catroppa C. (2012). 10 years outcome from childhood traumatic brain injury. Int J Dev Neurosci 30:217-224
7. Anderson VA, Catroppa C, Haritou F, Morse S, and Rosenfeld JV. (2005). Identifying factors contributing to child and family outcome 30 months after traumatic brain injury in children. J Neurol Neurosurg Psychiatry 76:401-408
8. Slomine BS, McCarthy ML, Ding R, et al. (2006). Health care utilization and needs after pediatric traumatic brain injury. Pediatrics 117:e663-674
9. Aitken ME, McCarthy ML, Slomine BS, et al. (2009). Family burden after traumatic brain injury in children. Pediatrics 123:199-206
10. Mammis A, McIntosh TK, and Maniker AH. (2009). Erythropoietin as a neuroprotective agent in traumatic brain injury Review. Surg Neurol 71:527-531
11. Dame C, Juul SE, and Christensen RD. (2001). The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate 79:228-235
12. Yatsiv I, Grigoriadis N, Simeonidou C, et al. (2005). Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 19:1701-1703
13. Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, and Iacopino DG. (2007). Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res 1182:99-105
14. Mahmood A, Lu D, Qu C, et al. (2007). Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg 107:392-397
15. Zhu L, Wang HD, Yu XG, et al. (2009). Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: In vitro and in vivo studies. Brain Res 1289:96-105
16. Polster BM, Robertson CL, Bucci CJ, Suzuki M, and Fiskum G. (2003). Postnatal brain development and neural cell differentiation modulate mitochondrial Bax and BH3 peptide-induced cytochrome c release. Cell Death Differ 10:365-370
17. Rice D, and Barone S, Jr. (2000). Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect 108:511-533
18. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, and Gassmann M. (1995). Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720
19. Juul SE, Yachnis AT, Rojiani AM, and Christensen RD. (1999). Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2:148-158
20. Noguchi CT, Asavaritikrai P, Teng R, and Jia Y. (2007). Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64:159-171
21. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, and Sasaki R. (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95:4635-4640
22. Shein NA, Grigoriadis N, Alexandrovich AG, et al. (2008). Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury. J Neurotrauma 25:112-123
23. Liao ZB, Zhi XG, Shi QH, and He ZH. (2008). Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 15:140-149
24. Liao ZB, Jiang GY, Tang ZH, et al. (2009). Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats. Neurol India 57:722-728
25. Xiong Y, Mahmood A, Qu C, et al. (2010). Erythropoietin improves histological and functional outcomes following traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma 27:205-215
26. Maiese K, Li F, and Chong ZZ. (2004). Erythropoietin in the brain: Can the promise to protect be fulfilled? Trends Pharmacol Sci 25:577-583
27. Chong ZZ, Kang JQ, and Maiese K. (2003). Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 138:1107-1118
28. Pavlica S, Milosevic J, Keller M, et al. (2012). Erythropoietin enhances cell proliferation and survival of human fetal neuronal progenitors in normoxia. Brain Res 1452:18-28
29. Xenocostas A, Cheung WK, Farrell F, et al. (2005). The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61:189-195
30. Juul SE, McPherson RJ, Farrell FX, Jolliffe L, Ness DJ, and Gleason CA. (2004). Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate 85:138-144
31. Schober ME, Block B, Beachy JC, Statler KD, Giza CC, and Lane RH. (2010). Early and sustained increase in the expression of hippocampal IGF-1, but not EPO, in a developmental rodent model of traumatic brain injury. J Neurotrauma 27:2011-2020
32. Antunes M, and Biala G. (2012). The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cognit Process 13:93-110
33. Bittigau P, Sifringer M, Pohl D, et al. (1999). Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 45:724-735
34. Pohl D, Bittigau P, Ishimaru MJ, et al. (1999). N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 96:2508-2513
35. DAmelio M, Cavallucci V, and Cecconi F. (2010). Neuronal caspase-3 signaling: Not only cell death. Cell Death Differ 17:1104-1114
36. Brines ML, Ghezzi P, Keenan S, et al. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531
37. Statler PA, McPherson RJ, Bauer LA, Kellert BA, and Juul SE. (2007). Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 61:671-675
38. Lieutaud T, Andrews PJ, Rhodes JK, and Williamson R. (2008). Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats. J Neurotrauma 25:1179-1185
39. Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, and Ferriero DM. (2009). Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Develop Neurosci 31:403-411
40. Reger ML, Hovda DA, and Giza CC. (2009). Ontogeny of rat recognition memory measured by the novel object recognition task. Develop Psychobiol 51:672-678
41. Paxinos G, and Charles W. (2005). The Rat Brain in Stereotaxic Coordinates.
42. Marvizon JC, Perez OA, Song B, Chen W, Bunnett NW. Grady EF, and Todd AJ. (2007). Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: Localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors. Neuroscience 148:250-265
43. Pierce DR, Hayar A, Williams DK, and Light KE. (2011). Olivary climbing fiber alterations in PN40 rat cerebellum following postnatal ethanol exposure. Brain Res 1378:54-65
44. Swigart RH. (1965). Polycythemia and right ventricular hypertrophy. Circ Res17:30-38
45. Rakusan K, Cicutti N, and Kolar F. (2001). Cardiac function, microvascular structure, and capillary hematocrit in hearts of polycythemic rats. Am J Physiol Heart Circ Physiol 281:H2425-2431
46. Broadbent NJ, Gaskin S, Squire LR, and Clark RE. (2010). Object recognition memory and the rodent hippocampus. Learn Mem 17:5-11
47. Scott HL, Tamagnini F, Narduzzo KE, et al. (2012). MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 36:2941-2948
48. McBride J, Zhao X, Nichols T, et al. (2013). Scalp EEG-based discrimination of cognitive deficits after traumatic brain injury using event-related Tsallis entropy analysis. IEEE Trans Biomed Eng 60: 90-96
49. Mandalis A, Kinsella G, Ong B, and Anderson V. (2007). Working memory and new learning following pediatric traumatic brain injury. Dev Neuropsychol 32:683-701
50. Scafidi S, Racz J, Hazelton J, McKenna MC, and Fiskum G. (2010). Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Develop Neurosci 32:480-487
51. Li YX, Ding SJ, Xiao L, Guo W, and Zhan Q. (2008). Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci Bull 24:89-95
52. AgarwalMK, Agarwal ML, AtharM, and Gupta S. (2004). Tocotrienolrich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3:205-211
53. Ammar HI, Saba S, Ammar RI, Elsayed LA, Ghaly WB, and Dhingra S. (2011). Erythropoietin protects against doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 301:H2413-2421
54. Lowthert L, Leffert J, Lin A, et al. (2012). Increased ratio of antiapoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol Mood Anxiety Dis 2:15
55. Srinivasan A, Li F, Wong A, et al. (1998). Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem 273:4523-4529
56. Chen G, Shi JX, Hang CH, Xie W, Liu J, and Liu X. (2007). Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: A potential neuroprotective mechanism of re- combinant human erythropoietin (rhEPO). Neurosci Lett 425:177-182
57. Dzietko M, Felderhoff-Mueser U, Sifringer M, et al. (2004). Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15:177-187
58. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, and Mayock DE. (2008). A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122:383-391
59. Wu YW, Bauer LA, Ballard RA, et al. (2012). Erythropoietin for neuroprotection in neonatal encephalopathy: Safety and pharmacokinetics. Pediatrics 130:683-691
60. Verdonck O, Lahrech H, Francony G, et al. (2007). Erythropoietin protects from post-traumatic edema in the rat brain. J Cereb Blood Flow Metab 27:1369-1376
61. Xiong Y, Lu D, Qu C, Goussev A, Schallert T, Mahmood A, and Chopp M. (2008). Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J Neurosurg 109:510-521
62. Sola A, Wen TC, Hamrick SE, and Ferriero DM. (2005). Potential for protection and repair following injury to the developing brain: A role for erythropoietin? Pediatr Res 57:110R-117R.
63. Kim SS, Lee KH, Sung DK, et al. (2008). Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. J Korean Med Sci 23:484-491
64. Bittigau P, Sifringer M, Felderhoff-Mueser U, and Ikonomidou C. (2004). Apoptotic neurodegeneration in the context of traumatic injury to the developing brain. Exp Toxicol Pathol 56:83-89
65. Anderson V, Catroppa C, Morse S, Haritou F, and Rosenfeld J. (2005). Functional plasticity or vulnerability after early brain injury? Pediatrics 116:1374-1382
66. Hagemeyer N, Boretius S, Ott C, et al. (2012). Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol Med 18:628-635
67. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, and Ferriero DM. (2007). Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Developmental Neuroscience 29:321-330
68. Zhang Y, Chopp M, Mahmood A, Meng Y, Qu C, and Xiong Y. (2012). Impact of inhibition of erythropoietin treatment-mediated neurogenesis in the dentate gyrus of the hippocampus on restoration of spatial learning after traumatic brain injury. Exp Neurol 235:336-344
69. Wang Y, Zhang ZG, Rhodes K, et al. (2007). Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 151:1377-1384
70. Li Y, Ogle ME, Wallace GC, Lu ZY, Yu SP, and Wei, L. (2008). Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice. Acta Neurochir Suppl 105:105-112.
71. Sargin D, Hassouna I, Sperling S, Siren AL, and Ehrenreich H. (2009). Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia 57:693-702
72. Tang Z, Sun X, Huo G, Xie Y, Shi Q, Chen S, Wang X, and Liao Z. (2013). Protective effects of erythropoietin on astrocytic swelling after oxygen-glucose deprivation and reoxygenation: Mediation through AQP4 expression and MAPK pathway. Neuropharmacology 67:8-15
73. Yamada M, Burke C, Colditz P, Johnson DW, and Gobe GC. (2011). Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain. Journal of Pathology 224:101-109
74. Liu J, Narasimhan P, Song YS, Nishi T, Yu F, Lee YS, and Chan PH. (2006). Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress. Glia 53:360-365
75. Vairano M, Dello Russo C, Pozzoli G, et al. (2002). Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 16:584-592
76. Ponce LL, Navarro JC, Ahmed O, and Robertson CS. (2012). Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology 20:31-38.